Cardiac Sympathetic Imaging With mIBG in Heart Failure

Ignasi Carrió, Martin R. Cowie, Junichi Yamazaki, James Udelson, Paolo G. Camici

Research output: Contribution to journalArticlepeer-review


Cardiac sympathetic imaging with meta-iodobenzylguanidine (mIBG) is a noninvasive tool to risk stratify patients with heart failure (HF). In patients with ischemic and nonischemic cardiomyopathy, cardiac mIBG activity is a very powerful predictor of survival. Cardiac sympathetic imaging can help in understanding how sympathetic overactivity exerts its deleterious actions, which may result in better therapy and outcome for patients with HF.

Original languageEnglish
Pages (from-to)92-100
Number of pages9
JournalJACC: Cardiovascular Imaging
Issue number1
Publication statusPublished - Jan 2010


  • cardiac sympathetic imaging
  • heart failure
  • mIBG
  • prognosis
  • sudden death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Cardiac Sympathetic Imaging With mIBG in Heart Failure'. Together they form a unique fingerprint.

Cite this